Institutional investors hold a majority ownership of THOR through the 90.27% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended March 2014, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEALTHINVEST PARTNERS AB Bought 287.0 Thousand shares of Thoratec Corp
SWEDBANK ROBUR FONDER AB Bought 259.8 Thousand shares of Thoratec Corp